Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders
Status:
Terminated
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to examine the efficacy and tolerability of short-term
omega-3 fatty acids monotherapy in youth with Autism Spectrum Disorders (ASD). The
investigators hypothesize that Omega-3 fatty acids will be efficacious in improving the core
and associated features of ASD in youth, and that Omega-3 fatty acids monotherapy will be
safe and well tolerated by youth with ASD. The secondary aim of this study is to examine the
neuropsychological effect of Omega-3 fatty acids monotherapy in youth with ASD. The
investigators hypothesize that omega-3 fatty acids will be efficacious in improving cognitive
functions in youth with ASD.